How are our sales looking?, page-17

I only bring the subject up because the last three announcements have this kinda fishy "distract the shareholders with this until we have something solid" vibe about them. It's just been worrying me that's all. We all expected the nasal balm patent to be filed and the Ooh medical Ann. Both had their potential priced in long before the the release to market. The sanitising robots Ann could have been kept quiet in my opinion until the trial was over as it may not even evenutate into anything and cause more harm than good. we are definitely due to be updated on the bottom line and the main reason we are all here, Sales. Don't you also think so?